Erasca, Inc. (ERAS) stock
ERASNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.89−1.22 (-8.07%)
Close on Nov 17, 2026Market cap $4.86BP/E –Yield 0.00%
Erasca cash
Cash and short-term investments held at the end of each period.
Erasca's cash was $384.30M at Jun 30, 2026. For fiscal 2025 it was $341.80M, up 14.6% from the year before. The highest annual figure on record is $435.60M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $341.80M | +14.6% |
| FY2024 | Dec 31, 2024 | $298.30M | -4.5% |
| FY2023 | Dec 31, 2023 | $312.40M | -28.3% |
| FY2022 | Dec 31, 2022 | $435.60M | +5.1% |
| FY2021 | Dec 31, 2021 | $414.50M | +249.2% |
| FY2020 | Dec 31, 2020 | $118.70M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $384.30M | -0.6% |
| Q1 FY2026 | Mar 31, 2026 | $408.50M | +34.1% |
| Q4 FY2025 | Dec 31, 2025 | $341.80M | +14.6% |
| Q3 FY2025 | Sep 30, 2025 | $362.40M | +13.6% |
| Q2 FY2025 | Jun 30, 2025 | $386.70M | -5.3% |
| Q1 FY2025 | Mar 31, 2025 | $304.60M | +2.3% |
| Q4 FY2024 | Dec 31, 2024 | $298.30M | -4.5% |
| Q3 FY2024 | Sep 30, 2024 | $318.90M | +7.5% |
| Q2 FY2024 | Jun 30, 2024 | $408.40M | +28.8% |
| Q1 FY2024 | Mar 31, 2024 | $297.70M | -23.6% |
| Q4 FY2023 | Dec 31, 2023 | $312.40M | -28.3% |
| Q3 FY2023 | Sep 30, 2023 | $296.70M | -16.6% |
| Q2 FY2023 | Jun 30, 2023 | $317.20M | -14.6% |
| Q1 FY2023 | Mar 31, 2023 | $389.70M | -0.7% |
| Q4 FY2022 | Dec 31, 2022 | $435.60M | +5.1% |
| Q3 FY2022 | Sep 30, 2022 | $355.90M | -26.9% |
| Q2 FY2022 | Jun 30, 2022 | $371.50M | +91.8% |
| Q1 FY2022 | Mar 31, 2022 | $392.50M | +130.9% |
| Q4 FY2021 | Dec 31, 2021 | $414.50M | +249.2% |
| Q3 FY2021 | Sep 30, 2021 | $486.60M | +684.6% |
| Q2 FY2021 | Jun 30, 2021 | $193.70M | +85.6% |
| Q1 FY2021 | Mar 31, 2021 | $169.99M | – |
| Q4 FY2020 | Dec 31, 2020 | $118.70M | – |
| Q3 FY2020 | Sep 30, 2020 | $62.02M | – |
| Q2 FY2020 | Jun 30, 2020 | $104.34M | – |
See a number that looks wrong?